eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2024
vol. 16
 
Share:
Send email
Share:
Case report

3D technique in superficial brachytherapy: New attitude in old field of mycosis fungoides

Helena Kamieniecka
1
,
Jacek Rutkowski
2

  1. Medical University of Gdańsk, Gdańsk, Poland
  2. Department of Oncology and Radiotherapy, University Clinical Centre in Gdańsk, Gdańsk, Poland
J Contemp Brachytherapy 2024; 16, 4: 310-313
DOI: https://doi.org/10.5114/jcb.2024.143212
Online publish date: 2024/09/20
Article file
- 3D technique in superficial.pdf  [0.23 MB]
Get citation
 
 
1. Miyagaki T. Diagnosis of early mycosis fungoides. Diagnostics 2021; 11: 1721.
2. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
3. Kamijo H, Miyagaki T. Mycosis fungoides and Sézary syndrome: Updates and review of current therapy. Curr Treat Options Oncol 2021; 22: 10.
4. Common Terminology Criteria for Adverse Events (CTCAE) US Department of Health and Human Services. National Institutes of Health National Cancer Institute, Version 4.03, June 14, 2010: 179.
5. Latzka J, Assaf C, Bagot M et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023. Eur J Cancer 2023; 195: 113343.
6. Hristov AC, Tejasvi T, Wilcox RA. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 2023; 98: 193-209.
7. Wennberg E, Richards PQ, Bain PA et al. Topical treatments for early-stage mycosis fungoides using Grading Recommendations Assessment, Development, and Evaluation (GRADE) criteria: A systematic review. JAAD Int 2021; 3: 26-41.
8. Zackheim HS. Treatment of patch-stage mycosis fungoides with topical corticosteroids. Dermatol Ther 2003; 16: 283-287.
9. Laube S, George SA. Adverse effects with PUVA and UVB phototherapy. J Dermatol Treat 2001; 12: 101-105.
10. Hoppe RT. Mycosis fungoides: radiation therapy. Dermatol Ther 2003; 16: 347-354.
11. Fionda B, Placidi E, Rosa E et al. Multilayer intensity modulated contact interventional radiotherapy (brachytherapy): Stretching the therapeutic window in skin cancer. J Contemp Brachytherapy 2023; 15: 220-223.
12. Chyrek AJ, Chicheł A, Burchardt WM et al. Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study. J Contemp Brachytherapy 2022; 14: 438-445.
13. Stephens H, Deans C, Schlect D, Kairn T. Development of a method for treating lower-eyelid carcinomas using superficial high dose rate brachytherapy. Phys Eng Sci Med 2020; 43: 1317-1325.
14. Tuček L, Sirák I, Hodek M et al. High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years. Brachytherapy 2023; 22: 496-502.
15. Guinot JL, Rembielak A, Perez-Calatayud J et al. GEC- ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 2018; 126: 377-385.
16. Korreman S, Rasch C, McNair H et al. The European Society of Therapeutic Radiology and Oncology–European Institute of Radiotherapy (ESTRO–EIR) report on 3D CT-based in-room image guidance systems: A practical and technical review and guide. Radiother Oncol 2010; 94: 129-144.
17. Shukla G, Lockamy V, Keller J et al. High dose rate (HDR) brachytherapy for mycosis fungoides of the wrist. Int J Clin Med 2015; 6: 154-157.
18. Thawani N, Jani S, Kang B et al. PO09: Treatment of facial folliculotropic mycosis fungoides with high dose rate brachytherapy in two fractions. Brachytherapy 2022; 21 Suppl: S74-S75.
19. DeSimone JA, Guenova E, Carter JB et al. Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol 2013; 69: 61-65.
20. Chyrek A, Bielęda G, Burchardt W et al. High-dose-rate brachytherapy of primary cutaneous B-cell lymphoma: the first reported case series. J Contemp Brachytherapy 2020; 12: 241-247.
21. Placidi E, Fionda B, Rosa E et al. Dosimetric impact of applying a model-based dose calculation algorithm for skin cancer brachytherapy (interventional radiotherapy). J Contemp Brachytherapy 2023; 15: 448-452.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.